Mohamed r. Daha

Q: What Schools Are Affiliated With Mohamed r. Daha

Mohamed r. Daha is affiliated with the following schools: Johns Hopkins University, University of Groningen, Leiden University

Mohamed r. Daha's AcademicInfluence.com Rankings

Mohamed r. Daha

Philosophy

#4312

World Rank

#6785

Historical Rank

Logic

#1805

World Rank

#2648

Historical Rank

philosophy Degrees

Mohamed r. Daha

Biology

#5624

World Rank

#8148

Historical Rank

Immunology

#279

World Rank

#290

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Mohamed r. Daha Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mohamed r. Daha's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. (1998) (736)
Control of the amplification convertase of complement by the plasma protein beta1H. (1976) (558)
Structures of complement component C3 provide insights into the function and evolution of immunity (2005) (518)
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases (2005) (436)
Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway1 (2001) (417)
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. (2006) (352)
Biochemical and functional characterization of the interaction between pentraxin 3 and C1q (2003) (348)
Direct binding of C1q to apoptotic cells and cell blebs induces complement activation (2002) (341)
Mannose‐binding lectin engagement with late apoptotic and necrotic cells (2003) (336)
The complement system in systemic autoimmune disease. (2010) (314)
Secretory IgA N- and O-Glycans Provide a Link between the Innate and Adaptive Immune Systems* (2003) (305)
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. (2005) (283)
Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. (1998) (273)
Opsonization with C1q and Mannose-Binding Lectin Targets Apoptotic Cells to Dendritic Cells1 (2004) (267)
Recognition and clearance of apoptotic cells: a role for complement and pentraxins. (2003) (253)
IL-10-producing macrophages preferentially clear early apoptotic cells. (2006) (241)
Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. (2009) (230)
Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. (2004) (228)
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. (1976) (222)
Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. (1995) (202)
Complement in organ transplantation. Contributions to inflammation, injury, and rejection. (1995) (193)
Functional characterization of the lectin pathway of complement in human serum. (2003) (190)
Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. (1991) (185)
Mini‐review: A pivotal role for innate immunity in the clearance of apoptotic cells (2004) (184)
The innate immune response. (2014) (180)
Activation of the alternative pathway of complement by human serum IgA (1987) (179)
Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. (2001) (176)
IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. (1991) (172)
Pros and cons for C4d as a biomarker. (2012) (169)
Maturation of dendritic cells abrogates C1q production in vivo and in vitro. (2004) (166)
Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. (1980) (162)
Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression. (2003) (162)
The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. (2000) (157)
The membrane attack complex of complement induces caspase activation and apoptosis (2002) (151)
Complement activation by (auto-) antibodies. (2011) (149)
Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. (1993) (147)
Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. (1999) (144)
Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. (2000) (144)
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. (2010) (139)
Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. (1984) (137)
Evidence That Complement Protein C1q Interacts with C-Reactive Protein through Its Globular Head Region1 (2006) (137)
Activity of Human IgG and IgA Subclasses in Immune Defense Against Neisseria meningitidis Serogroup B1 (2001) (137)
The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells (2000) (136)
The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. (1993) (136)
The lectin‐like domain of thrombomodulin interferes with complement activation and protects against arthritis (2006) (135)
Miller Fisher anti‐GQ1b antibodies: α‐Latrotoxin–like effects on motor end plates (1999) (135)
The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. (1985) (135)
Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. (1979) (134)
Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population (2018) (133)
The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. (1998) (128)
Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. (2012) (128)
Interactions of the Extracellular Matrix Proteoglycans Decorin and Biglycan with C1q and Collectins1 (2005) (127)
Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. (2006) (127)
Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. (2003) (126)
Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. (1997) (126)
INCREASED EXPRESSION OF IL‐15 IN THE SYNOVIUM OF PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED WITH PATIENTS WITH YERSINIA‐INDUCED ARTHRITIS AND OSTEOARTHRITIS (1997) (125)
Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations. (1981) (124)
Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. (2005) (123)
Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. (1993) (121)
Human renal epithelial cells produce the long pentraxin PTX3. (2005) (120)
Association Between Mannose‐Binding Lectin Levels and Graft Survival in Kidney Transplantation (2005) (118)
Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. (1985) (118)
Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. (2007) (113)
Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. (1996) (111)
Factor B structure provides insights into activation of the central protease of the complement system (2007) (107)
Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation12 (2008) (105)
Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1. (1990) (105)
The Inhibiting Fc Receptor for IgG, FcγRIIB, Is a Modifier of Autoimmune Susceptibility (2011) (104)
Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. (1996) (103)
Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. (1995) (103)
Is the proximal tubular cell a proinflammatory cell? (2000) (103)
Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. (1994) (101)
Specific Inhibition of the Classical Complement Pathway by C1q-Binding Peptides1 (2001) (101)
Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. (1989) (100)
Inhibition of activation of the classical pathway of complement by human neutrophil defensins. (1998) (100)
The current status of neutrophil cytoplasmic antibodies. (1989) (100)
Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. (1994) (98)
Studies on the sensitivity to complement‐mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor) (1989) (98)
Immune Evasion of Leptospira Species by Acquisition of Human Complement Regulator C4BP (2008) (96)
Complement activation by tubular cells is mediated by properdin binding. (2008) (96)
Systemic Complement Activation in Deceased Donors Is Associated With Acute Rejection After Renal Transplantation in the Recipient (2011) (95)
Antibody‐mediated activation of the classical pathway of complement may compensate for mannose‐binding lectin deficiency (2004) (92)
Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. (2006) (92)
Crosstalk between Complement and Toll‐like Receptor Activation in Relation to Donor Brain Death and Renal Ischemia‐Reperfusion Injury (2011) (92)
IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes. (1987) (92)
Detachment and cytolysis of human endothelial cells by proteinase 3 (1994) (91)
C3 requirements for formation of alternative pathway C5 convertase. (1976) (91)
Complete and partial deficiencies of complement factor D in a Dutch family. (1989) (90)
Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus (2003) (89)
Properdin deficiency: molecular basis and disease association. (1999) (89)
Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. (1999) (88)
The spectrum of phenotypes caused by variants in the CFH gene. (2009) (87)
Role of complement in IgA nephropathy (2015) (86)
IL-1α stimulated TNFα production by cultured human proximal tubular epithelial cells (1992) (86)
Hypoxia and Complement-and-Coagulation Pathways in the Deceased Organ Donor as the Major Target for Intervention to Improve Renal Allograft Outcome (2015) (85)
Immune modulation of human dendritic cells by complement (2007) (84)
Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. (1995) (84)
Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies. (1984) (84)
Transforming growth factor-β1 regulates chemokine and complement production by human proximal tubular epithelial cells (1998) (81)
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL‐1 and interferon‐gamma (1994) (80)
The clinical implications and the pathogenetic significance of circulating immune complexes in infective endocarditis. (1981) (80)
Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma. (1989) (80)
Tubular Epithelial Cells: A Critical Cell Type in the Regulation of Renal Inflammatory Processes (1999) (79)
IFN-γ mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells (1993) (79)
A Regulatory Role for Complement in Innate Immunity and Autoimmunity (2004) (78)
Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. (2010) (78)
Role of complement in innate immunity and host defense. (2011) (77)
Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies. (1989) (77)
Immunoglobulin M–Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation (1999) (77)
Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy. (1983) (77)
Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons. (2009) (77)
Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation (2010) (76)
Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. (2007) (76)
Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. (1990) (75)
Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. (1994) (75)
Cell‐mediated autoimmunity in patients with Wegener's granulomatosis (WG) (1995) (75)
THE CLINICAL SIGNIFICANCE OF ALLOSPECIFIC ANTIBODIES AGAINST ENDOTHELIAL CELLS DETECTED WITH AN ANTIBODY‐DEPENDENT CELLULAR CYTOTOXICITY ASSAY FOR VASCULAR REJECTION AND GRAFT LOSS AFTER RENAL TRANSPLANTATION (1993) (74)
Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. (1994) (74)
Activation of complement by human serum IgA, secretory IgA and IgA1 fragments. (1988) (74)
High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. (2001) (74)
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes (1981) (74)
Characterization of anti‐endothelial cell antibodies in systemic lupus erythematosus (SLE) (1991) (73)
Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3 (1993) (73)
Identification of Tubular Heparan Sulfate as a Docking Platform for the Alternative Complement Component Properdin in Proteinuric Renal Disease* (2010) (73)
Mannan‐Binding Lectin Mediates Renal Ischemia/Reperfusion Injury Independent of Complement Activation (2012) (73)
The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. (1999) (72)
Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells. (1999) (71)
A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus. (2005) (71)
A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone (2006) (71)
Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1α (IL-1α) and other cytokines (1994) (71)
Role of macromolecular IgA in IgA nephropathy. (2005) (70)
The Complement System in Dialysis: A Forgotten Story? (2018) (70)
Complement-endothelial cell interactions: pathophysiological implications. (1999) (70)
Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. (1996) (70)
Relative roles of decay‐accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement‐mediated lysis (1992) (70)
The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis. (1999) (69)
Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor. (1978) (69)
Hereditary C6 deficiency in a strain of PVG/c rats (1994) (68)
Donor-specific lysis of human kidney proximal tubular epithelial cells by renal allograft-infiltrating lymphocytes. (1989) (68)
Isolation and characterization of feline C3 and evidence for the immune complex pathogenesis of feline infectious peritonitis. (1980) (68)
Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. (1989) (68)
Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89). (1999) (67)
Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. (1999) (67)
Expression and function of Fas (CD95) on human renal tubular epithelial cells. (1997) (66)
Antibody, immune complexes and complement activity fluctuations in experimental feline infectious peritonitis (1982) (66)
Regulation of Glomerular Epithelial Cell Production of Fibronectin and Transforming Growth Factor-β by High Glucose, Not by Angiotensin II (1997) (66)
Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies. (1980) (65)
Reversible differentiation of pro- and anti-inflammatory macrophages. (2013) (65)
Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. (1996) (64)
The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. (1988) (64)
Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation (2008) (63)
Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma. (2005) (63)
A pathogenic role for secretory IgA in IgA nephropathy. (2006) (63)
Mannose-binding lectin levels during pregnancy: a longitudinal study. (2007) (61)
Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis. (2007) (61)
The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay. (2003) (60)
Complement and the kidney: what the nephrologist needs to know in 2006? (2005) (60)
Heterozygous and homozygous factor H deficiency states in a Dutch family (1996) (60)
NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase. (2005) (60)
Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation. (1989) (60)
In Situ Deposition of Complement in Human Acute Brain Ischaemia (2009) (60)
Role of complement in innate immunity and infections. (2010) (59)
Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. (1988) (59)
Intracellular localization of the human receptor for the globular domains of C1q. (1997) (59)
Inhibition of Complement Component C3 Reduces Vein Graft Atherosclerosis in Apolipoprotein E3–Leiden Transgenic Mice (2006) (59)
The clearance of apoptotic cells by complement. (2007) (59)
Sex matters: Systemic complement activity of female C57BL/6J and BALB/cJ mice is limited by serum terminal pathway components. (2016) (58)
IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. (1998) (58)
Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89. (1999) (58)
Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis. (1995) (58)
Antibody, immune complexes, and complement activity fluctuations in kittens with experimentally induced feline infectious peritonitis. (1982) (57)
The role of secretory IgA and complement in IgA nephropathy. (2008) (57)
Distinct in vitro Complement Activation by Various Intravenous Iron Preparations (2016) (57)
Proteinase 3 interacts with a 111-kD membrane molecule of human umbilical vein endothelial cells. (2000) (57)
CD59 expressed by human endothelial cells functions as a protective molecule against complement‐mediated lysis (1992) (56)
Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family. (1983) (56)
Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor. (1981) (56)
Active Heymann nephritis in complement component C6 deficient rats. (1995) (56)
Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection. (1979) (56)
CYTOMEGALOVIRUS DIRECTLY ENHANCES MHC CLASS I AND INTERCELLULAR ADHESION MOLECULE‐1 EXPRESSION ON CULTURED PROXIMAL TUBULAR EPITHELIAL CELLS (1993) (55)
Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts. Predisposing factors, histology, immunohistochemistry, and relation to outcome. (1996) (55)
Complement in glomerular injury (2007) (55)
Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis. (2010) (55)
Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3 (1992) (54)
Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. (2007) (54)
Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA‐mediated endothelial damage through ADCC? (1994) (54)
Pathogenesis of naturally acquired bovine respiratory syncytial virus infection in calves: evidence for the involvement of complement and mast cell mediators. (1989) (54)
In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts. (1994) (54)
The pathophysiology of protein-overload proteinuria. (1987) (53)
Evidence for a novel chemotactic C1q domain-containing factor in the leech nerve cord. (2009) (53)
Factor H and Properdin Recognize Different Epitopes on Renal Tubular Epithelial Heparan Sulfate* (2012) (53)
HUMAN COMPLEMENT ACTIVATION VIA THE ALTERNATIVE PATHWAY ON PORCINE ENDOTHELIUM INITIATED BY IgA ANTIBODIES (1995) (53)
Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles. (2005) (52)
Interleukin-1α enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro (1996) (52)
Rare Genetic Variants Associated With Development of Age-Related Macular Degeneration. (2016) (52)
Distinctive roles of neutrophils and monocytes in anti-thy-1 nephritis. (2000) (52)
Rat C‐reactive protein activates the autologous complement system (2003) (51)
Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb. (1982) (51)
Complement Dependent Amplification of the Innate Response to a Cognate Microbial Ligand by the Long Pentraxin PTX31 (2007) (51)
Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection. (1998) (50)
The role of complement in innate, adaptive and eosinophil-dependent immunity to the nematode Nippostrongylus brasiliensis. (2008) (50)
Activation of human complement by mouse and mouse/human chimeric monoclonal antibodies (1993) (50)
A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement. (1998) (50)
A Possible Role of CD46 for the Protection In Vivo of Human Renal Tumor Cells from Complement-Mediated Damage (2000) (49)
Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA. (1988) (49)
Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89. (1998) (49)
Synergistic effect of IL-1alpha, IFN-gamma, and TNF-alpha on RANTES production by human renal tubular epithelial cells in vitro. (1998) (49)
Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells (1991) (49)
Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1. (2005) (48)
Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein. (1980) (48)
Analysis of T cell lines from rejecting renal allografts. (1993) (48)
Endothelial cell lysis induced by lymphokine‐activated human peripheral blood mononuclear cells (1987) (48)
The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases. (1997) (48)
The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms. (1990) (47)
Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration (2014) (47)
FcαRI/CD89 Circulates in Human Serum Covalently Linked to IgA in a Polymeric State1 (2002) (47)
Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway. (2004) (47)
The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro (1988) (46)
Functional deficiency of complement factor D in a monozygous twin. (1984) (46)
Anti‐C1q autoantibodies in murine lupus nephritis (2004) (46)
Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-beta1. (2003) (46)
Differential expression of complement components in human fetal and adult kidneys. (1996) (46)
Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus (2006) (46)
Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation. (2007) (46)
Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration. (2018) (46)
The complement system in the peripheral nerve: friend or foe? (2008) (45)
Impact of the Common Genetic Associations of Age-Related Macular Degeneration upon Systemic Complement Component C3d Levels (2014) (45)
Association of Complement C3 Gene Variants with Renal Transplant Outcome of Deceased Cardiac Dead Donor Kidneys (2012) (45)
Tumor necrosis factor α-308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome (1994) (45)
Regulation of the function of the first component of complement by human C1q receptor (1995) (45)
Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. (2001) (45)
Structure of complement component C2A: implications for convertase formation and substrate binding. (2006) (45)
Role of complement in innate and autoimmunity. (2005) (44)
Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus. (1980) (44)
Myeloperoxidase Directs Properdin-Mediated Complement Activation (2013) (44)
Apoptosis of cultured rat glomerular mesangial cells induced by IgG2a monoclonal anti-Thy-1 antibodies. (1996) (43)
Immunoglobulin A: interaction with complement, phagocytic cells and endothelial cells. (1991) (43)
Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes. (1997) (43)
Complement and renal disease. (2003) (43)
Size‐dependent effect of IgA on the IgA Fc receptor (CD89) (1997) (43)
Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids (2002) (42)
Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig‐to‐human xenotransplantation models (2001) (42)
Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. (1996) (42)
Porcine islet cells of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms. (1996) (41)
Complement Activation Levels Are Related to Disease Stage in AMD (2020) (41)
Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. (2013) (40)
Both Complement and IgG Fc Receptors Are Required for Development of Attenuated Antiglomerular Basement Membrane Nephritis in Mice1 (2009) (40)
Allergy is a protective factor against age-related macular degeneration. (2014) (40)
IgD immune complex vasculitis in a patient with hyperimmunoglobulinemia D and periodic fever. (1990) (40)
MIP‐3α/CCL20 in Renal Transplantation and Its Possible Involvement as Dendritic Cell Chemoattractant in Allograft Rejection (2005) (40)
Pathogenesis of IgA nephropathy (1992) (40)
IgA antibodies directed against cytoplasmic antigens of polymorphonuclear leukocytes in patients with Henoch-Schoenlein purpura. (1987) (40)
Dendritic cell and macrophage subsets in the handling of dying cells. (2006) (40)
Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion. (2009) (40)
Further evidence for the antibody nature of C3 nephritic factor (C3NeF). (1979) (39)
The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase function. (1977) (39)
Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates. (1982) (38)
Sequential development of anti-GBM nephritis and ANCA-associated Pauci-immune glomerulonephritis. (1999) (38)
New insights into the pathogenesis of IgA nephropathy (2014) (38)
An acute model for IgA‐mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies (1993) (38)
A Novel Role of Complement Factor C1q in Augmenting the Presentation of Antigen Captured in Immune Complexes to CD8+ T Lymphocytes1 (2007) (38)
Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy. (1999) (38)
Histomorphometric correlates of renal failure in IgA nephropathy. (1998) (38)
The specific detection of IgA in immune complexes. (1981) (38)
Dendritic cells and complement: at the cross road of innate and adaptive immunity. (2004) (37)
Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation. (2005) (37)
Severe leukocytoclastic vasculitis of the skin in a patient with essential mixed cryoglobulinemia treated with high-dose gamma-globulin intravenously. (1988) (37)
Soluble aggregates of IgG and immune complexes enhance IL-6 production by renal mesangial cells. (1993) (37)
Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large (2007) (37)
Heparin/heparan sulphate interactions with complement--a possible target for reduction of renal function loss? (2014) (37)
T-cell receptors and ICAM-1 expression in renal allografts during rejection (1991) (36)
Isolation and characterization of the third component of rat complement. (1979) (36)
Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling (2018) (36)
Kupffer cell depletion in vivo results in clearance of large‐sized IgA aggregates in rats by liver endothelial cells (1991) (36)
Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia? (2020) (36)
Infectious Complications After Simultaneous Pancreas-Kidney Transplantation: A Role for the Lectin Pathway of Complement Activation (2008) (36)
Complement production and regulation by dendritic cells: molecular switches between tolerance and immunity. (2008) (36)
Cytokine cross-talk between tubular epithelial cells and interstitial immunocompetent cells (2001) (35)
Monomeric and polymeric IgA show a similar association with the myeloid FcalphaRI/CD89. (2007) (35)
Detection of three single nucleotide polymorphisms in the gene encoding mannose-binding lectin in a single pyrosequencing reaction. (2006) (35)
Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia‐reperfusion injury (2017) (35)
Xenotransplantation: in vitro analysis of synthetic α-galactosyl inhibitors of human anti-Galα1→3Gal IgM and IgG antibodies (2000) (35)
Possible involvement of terminal complement complex in active Heymann nephritis. (1985) (35)
An association between homozygous C3 deficiency and low levels of anti‐pneumococcal capsular polysaccharide antibodies (1992) (34)
Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. (2011) (34)
Complexes of IgA with FcαRI/CD89 are not specific for primary IgA nephropathy (2003) (34)
Urinary properdin excretion is associated with intrarenal complement activation and poor renal function. (2010) (34)
Enhanced Ig production by human peripheral lymphocytes induced by aggregated C1q. (1990) (34)
In C 57 Bl / 6 mice FcγRIIB deficiency amplifies spontaneous autoimmunity caused by other loci (2009) (34)
Complement in Serum and Dialysate in Children on Continuous Ambulatory Peritoneal Dialysis (1995) (34)
Differential effects of angiotensin II and transforming growth factor beta on the production of heparan sulfate proteoglycan by mesangial cells in vitro. (1996) (34)
Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific. (1993) (34)
Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement. (1979) (34)
Natural IgM antibodies are involved in the activation of complement by hypoxic human tubular cells. (2011) (34)
Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis (2005) (34)
Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane (1998) (33)
CIRCULATING IMMUNE COMPLEXES AND THYROID-STIMULATING IMMUNOGLOBULINS BEFORE, DURING, AND AFTER ANTITHYROID DRUG THERAPY IN PATIENTS WITH GRAVES' DISEASE (1980) (33)
Detection of intracellular interferon‐γ by light microscopy using an immunoperoxidase technique: correlation with the corresponding mRNA and protein product (1993) (33)
Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features. (1980) (32)
Integrating metabolomics, genomics and disease pathways in age-related macular degeneration: The EYE-RISK Consortium. (2020) (32)
Immunological Function of Tubular Epithelial Cells: The Functional Implications of CD40 Expression (2000) (32)
Both IgG and IgM anti‐pig antibodies induce complement activation and cytotoxicity (2001) (31)
IFN-gamma mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. (1993) (31)
MBL and C1q compete for interaction with human endothelial cells. (2007) (31)
Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro. (1995) (31)
Therapeutic inhibition of the early phase of complement activation. (2002) (31)
Combined glomerular deposition of polymeric rat IgA and IgG aggravates renal inflammation. (2000) (31)
Immunoelectron microscopic visualization of the transcytosis of low density lipoproteins in perfused rat arteries. (1989) (30)
Activation of rat complement by soluble and insoluble rat IgA immune complexes (1988) (30)
IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells. (1992) (30)
Biocompatibility and Performance of a Modified Cellulosic and a Synthetic High Flux Dialyzer: A Randomized Crossover Comparison Between Cellulose Triacetate and Polysulphon (1995) (30)
Schistosoma mansoni circulating anodic antigen but not circulating cathodic antigen interacts with complement component C1q (1993) (30)
Renal tubular epithelial cell death and cyclosporin A. (2002) (29)
IgA nephropathy: new insights into the role of complement. (2018) (29)
Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP. (2006) (29)
Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. (1997) (29)
Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1 alpha (IL-1 alpha) and other cytokines. (1994) (29)
Analysis of Cerebrospinal Fluid Inflammatory Mediators in Chronic Complex Regional Pain Syndrome Related Dystonia (2008) (29)
Mannose‐binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions (2008) (29)
Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy (2018) (28)
Epithelial- and endothelial-cell specificity of renal graft infiltrating T cells. (1998) (28)
Characterisation of the rat and mouse homologues of gC1qBP, a 33 kDa glycoprotein that binds to the globular `heads' of C1q (1997) (27)
Tissue-specific characteristics of cytotoxic graft-infiltrating T cells during renal allograft rejection. (1997) (27)
A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo (2016) (27)
The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages. (1979) (26)
Autoantibodies to neutrophil cytoplasmic enzymes in Felty's syndrome. (1993) (26)
Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections. (1982) (26)
C1-Inhibitor Treatment Decreases Renal Injury in an Established Brain-Dead Rat Model (2017) (26)
New insight into the effects of heparinoids on complement inhibition by C1‐inhibitor (2016) (26)
Methods for the detection of anti-endothelial antibodies by enzyme-linked immunosorbent assay. (1991) (26)
Production of Inflammatory Mediators and Cytokine Responsiveness of an SV40-Transformed Human Proximal Tubular Epithelial Cell Line (1998) (26)
Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor. (1982) (25)
Properdin and factor H production by human dendritic cells modulates their T‐cell stimulatory capacity and is regulated by IFN‐γ (2017) (25)
Binding and Activation of the First Complement Component by Soluble Immune Complexes: Effect of Complex Size and Composition (1984) (25)
Autoantibodies to complement components. (2001) (25)
CsA, FK506, corticosteroids and rapamycin inhibit TNFα production by cultured PTEC (1993) (24)
Complement Activation by Ceramide Transporter Proteins (2014) (24)
Complement-mediated endothelial cell damage in immune complex vasculitis of the skin: ultrastructural localization of the membrane attack complex. (1989) (24)
Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages. (1981) (24)
Activation of the lectin pathway in murine lupus nephritis. (2005) (24)
Pancreatitis-associated protein: a putative marker for pancreas graft rejection. (1997) (24)
Cytokines Affect Resistance of Human Renal Tumour Cells to Complement‐Mediated Injury (2003) (24)
Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. (1998) (24)
Intracellular localization of glycosyl-phosphatidylinositol-anchored CD67 and FcRIII (CD16) in affected neutrophil granulocytes of patients with paroxysmal nocturnal hemoglobinuria. (1991) (24)
The effects of aortic reconstruction and collagen impregnation of Dacron prostheses on the complement system. (1992) (24)
Cytokine-regulated production of the major histocompatibility complex class-III-encoded complement proteins factor B and C4 by human glomerular mesangial cells. (1995) (24)
Lymph node cells from rats with Heymann's nephritis produce in vitro autoantibodies directed against purified renal tubular antigen. (1984) (24)
Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells. (1996) (24)
The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases. (2015) (24)
The Complement Inhibitor Low Molecular Weight Dextran Sulfate Prevents TLR4-Induced Phenotypic and Functional Maturation of Human Dendritic Cells1 (2008) (23)
Intracellular localization and de novo synthesis of FcRIII in human neutrophil granulocytes. (1990) (23)
Activation of complement by bovine respiratory syncytial virus-infected cells. (1989) (23)
Fc alpha RI/CD89 circulates in human serum covalently linked to IgA in a polymeric state. (2002) (23)
Campylobacter jejuni bacteraemia as a cause of recurrent fever in a patient with hypogammaglobulinaemia. (1986) (23)
Bortezomib, C1‐Inhibitor and Plasma Exchange Do Not Prolong the Survival of Multi‐Transgenic GalT‐KO Pig Kidney Xenografts in Baboons (2015) (23)
Immune deposition of C1q and anti-C1q antibodies in the kidney is dependent on the presence of glomerular IgG. (2003) (23)
Opsonic Activity of Cord Blood Sera against Various Species of Microorganism (1985) (23)
Composition of IgA-containing circulating immune complexes in IgA nephropathy. (1988) (23)
Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition. (2004) (22)
Low mannose-binding lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic south asians. a prospective cohort study (2011) (22)
Elimination of soluble 123I-labeled aggregates of IgG in patients with systemic lupus erythematosus. Effect of serum IgG and numbers of erythrocyte complement receptor type 1. (1991) (22)
The role of complement in autoimmune renal disease (2006) (22)
Immunoglobulin A subclass measurement in serum and saliva: sensitivity of detection of dimeric IgA2 in ELISA depends on the antibody used. (1995) (22)
The autoimmune response in active Heymann's nephritis in Lewis rats is regulated by T-lymphocyte subsets. (1985) (22)
An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. (2004) (22)
Role of Tubular Cells in Progressive Renal Disease (1999) (22)
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection. (1977) (22)
The IgA‐Binding Lectin Jacalin Induces Complement Activation by Inhibition of ‐Inactivator Function (1987) (21)
Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo. (1986) (21)
Mechanism of steroid action in renal epithelial cells. (2004) (21)
Schistosoma mansoni: complement activation by antigenic preparations. (1981) (21)
Systemic effects of collagen-impregnated aortoiliac Dacron vascular prostheses on platelet activation and fibrin formation. (1991) (21)
Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family. (1982) (21)
Antigen-antibody complexes enhance the production of complement component C3 by human mesangial cells. (1997) (21)
In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation (1992) (21)
Membrane attack complex of complement in leukocytoclastic vasculitis of the skin. Presence and possible pathogenetic role. (1987) (21)
Is there a role for locally produced complement in renal disease? (2000) (20)
Compliments from complement: A fourth pathway of complement activation? (2006) (20)
Steroid Responsiveness of Renal Epithelial Cells (2003) (20)
Serum killing of Ureaplasma parvum shows serovar-determined susceptibility for normal individuals and common variable immuno-deficiency patients. (2012) (20)
In vivo activation of complement by IgA in a rat model (1992) (20)
Uveitis and anti‐neutrophil cytoplasmic antibodies (1994) (20)
Recognition of a tissue-specific polymorphism by graft infiltrating T-cell clones isolated from a renal allograft with acute rejection. (1994) (20)
Emerging role of the mannose-binding lectin-dependent pathway of complement activation in clinical organ transplantation (2011) (20)
Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients (2018) (19)
Both Kupffer cells and liver endothelial cells play an important role in the clearance of IgA and IgG immune complexes. (1992) (19)
Mannose-binding lectin and the kidney. (2007) (19)
Isolation, culture, characterization and use of human renal tubular epithelial cells. (2001) (19)
Antibody-mediated activation of the classical complement pathway in xenograft rejection. (2002) (19)
S fimbriae of uropathogenic Escherichia coli bind to primary human renal proximal tubular epithelial cells but do not induce expression of intercellular adhesion molecule 1 (1995) (19)
Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF). (1976) (19)
The lectin pathway in renal disease: old concept and new insights (2018) (19)
Can eculizumab be discontinued in aHUS? (2016) (18)
Complement Split Product C5a Mediates the Lipopolysaccharide‐Induced Mobilization of Cfu‐S and Haemopoietic Progenitor Cells, But Not the Mobilization Induced By Proteolytic Enzymes (1986) (18)
Isolation of a protein complex from purulent sputum consisting of proteinase-3 and alpha 1-antitrypsin reactive with anti neutrophil cytoplasmic antibodies. (1993) (18)
Efficient induction of apoptosis in cultured rat glomerular mesangial cells by dimeric monoclonal IgA anti-Thy-1 antibodies. (1997) (18)
Renal allograft-infiltrated lymphocytes and proximal tubular cells: further analysis of donor-specific lysis. (1990) (18)
Alternative splicing of IgA Fc receptor (CD89) transcripts. (1996) (18)
Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein. (1996) (18)
Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians (2009) (18)
Effects of soluble aggregates of IgG on the binding, uptake and degradation of the Clq subcomponent of complement by adherent guinea pig peritoneal macrophages (1985) (18)
Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin. (2016) (18)
Evaluation by histology, immunohistology and PCR of protocollized renal biopsies 1 week post-transplant in relation to subsequent rejection episodes. (1995) (18)
Value of anti-neutrophil cytoplasmic autoantibodies and other laboratory parameters in follow-up of vasculitis. (1990) (18)
Fundamental and clinical aspects of anti neutrophil cytoplasmic antibodies (ANCA). (1992) (18)
Activation of factor B of the complement system by kallikrein and its light chain. (1985) (17)
Complement depletion abolishes IgA-mediated glomerular inflammation in rats. (1994) (17)
[Complement deficiencies and meningococcal disease in The Netherlands]. (1993) (17)
ANALYSIS OF CYTOKINE PRODUCTION BY GRAFT‐INFILTRATING CELLS ISOLATED FROM REJECTING RENAL ALLOGRAFTS (1994) (17)
Carrier detection by microsatellite haplotyping in 10 properdin type 1‐deficient families (1996) (17)
The effect of lidocaine on the processing of soluble immune aggregates and immune complexes by peritoneal macrophages. (1980) (17)
Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients (2016) (17)
Dendritic cells of IgA nephropathy patients have an impaired capacity to induce IgA production in naïve B cells. (2005) (17)
C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates. (1983) (17)
Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro* (2016) (17)
Enzyme-labelled antibody-avidin conjugates: new flexible and sensitive immunochemical reagents. (1996) (17)
Functional assessment of mouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury. (2015) (17)
Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy. (2003) (17)
Induction of mesangial interleukin-6 synthesis by apoptotic U937 cells and monocytes. (1997) (17)
Direct and indirect measurement of urinary kallikrein excretion in patients with essential hypertension and normotensives: relation to age and plasma renin and aldosterone levels (1984) (17)
High Normal Serum Levels of C3 and C1 Inhibitor, Two Acute-Phase Proteins Belonging to the Complement System, Occur More Frequently in Patients with Crohn's Disease Than Ulcerative Colitis (2003) (17)
Reestablishment of self tolerance by suppressor T-cells after active Heymann's nephritis. (1986) (16)
IgM, IgG, and IgA antibodies in human sera directed against porcine islets of Langerhans. (1993) (16)
Expression of the IL-2 receptor on human renal proximal tubular epithelial cells. (1997) (16)
Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies. (2000) (16)
C1q as antigen in humoral autoimmune responses. (1998) (16)
Binding of human IgA1 and IgA1 fragments to jacalin. (1989) (16)
A novel ELISA assay for the detection of C3 nephritic factor. (1993) (16)
Unexpected role for properdin in complement C3 glomerulopathies. (2013) (16)
Isolation, characterization, and mechanism of action of rat beta 1H. (1982) (16)
Circulating IgA immune complexes and skin IgA deposits in liver disease relation to liver histopathology (1988) (16)
Macrophage Activation by Interferon or Interferon Inducers (1980) (16)
Deposition of IgA in primary IgA nephropathy: it takes at least four to tango. (2013) (16)
Clearance kinetics and tissue distribution of aggregated human serum IgA in rats. (1989) (15)
The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages. (1982) (15)
Different functions for specific guinea pig IgG1 and IgG2 in the lysis of sheep erythrocytes by C4-deficient guinea pig serum. (1981) (15)
Involvement of the complement system in the pathogenesis of pulmonary leukostasis in experimental myelocytic leukemia. (1993) (15)
Induction of microhematuria by an IgA isotype switch variant of a monoclonal anti-Thy-1.1 antibody in the rat. (1996) (15)
Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients (2016) (15)
Immunopathogenetic aspects of IgA nephropathy. (1989) (15)
Mechanisms of mesangial injury in glomerular diseases. (2000) (15)
Interleukin-1 alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro. (1996) (15)
Fc‐ and Complement Receptor‐Dependent Degradation of Soluble Immune Complexes and Stable Immunoglobulin Aggregates by Guinea Pig Monocytes, Peritoneal Macrophages, and Kupffer Cells (1984) (15)
Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells (1996) (15)
Induction of Renal Cell Apoptosis by Antibodies and Complement (2001) (14)
Apoptosis of acinar cells in pancreas allograft rejection. (1997) (14)
The role of unconventional alloantigens in interstitial and vascular rejection after renal transplantation. (1994) (14)
Extrahepatic C6 is as effective as hepatic C6 in the generation of renal C5b-9 complexes. (1997) (14)
ASSOCIATION OF RHEUMATOD FACTORS IN RENAL TRANSPLANT RECIPIENTS WITH CYTOMEGALOVIRUS INFECTION AND NOT WITH REJECTION (1987) (13)
Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma. (2012) (13)
Immunopathological abnormalities in the normal skin of patients with rheumatoid arthritis in relation to clinical and serological findings: a one year follow up study. (1987) (13)
Macromolecular IgA in the circulation and mesangial deposits in patients with primary IgA nephropathy. (1984) (13)
Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients (2019) (13)
Stabilization of the amplification convertase of complement by monoclonal antibodies directed against human factor B. (1984) (13)
The Serum Complement System in Children on Continuous Ambulatory Peritoneal Dialysis (1993) (13)
Clearance and Glomerular Localization of Preformed DNP Anti‐DNP Immune Complexes (1979) (13)
Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease. (2018) (13)
Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s. (1983) (13)
Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B. (1976) (12)
Size-dependent effect of IgA on the IgA Fc receptor (CD89) (1997) (12)
In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates. (1985) (12)
Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement. (1981) (12)
Functional assessment of rat complement pathway activities and quantification of soluble C5b-9 in an experimental model of renal ischemia/reperfusion injury. (2014) (12)
Studies on the mechanisms of allergen-induced activation of the classical and lectin pathways of complement. (2003) (12)
Characterization of Neisseria meningitidis Strains Causing Disease in Complement-Deficient and Complement-Sufficient Patients (1998) (12)
Rat polymeric IgA binds C1q, but does not activate C1. (1990) (12)
Complement Therapeutics in the Multi-Organ Donor: Do or Don't? (2019) (12)
Arteriolar C4d in IgA Nephropathy: A Cohort Study. (2020) (12)
The Involvement of Kupffer Cells in the Clearance of High Molecular Weight Rat IgA Aggregates in Rats (1990) (12)
Complement-mediated solubilization of rat IgA immune precipitates. (1987) (12)
Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus. (1984) (11)
Grand Challenges in Molecular Innate Immunity (2011) (11)
Erratum to: Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients (2016) (11)
Acute effect of passive Heymann nephritis on renal blood flow and glomerular filtration rate in the rat: role of the anaphylatoxin C5a and the alpha-adrenergic nervous system. (1992) (11)
Binding of human IgA1 to rat peritoneal macrophages. (1988) (11)
C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells. (1993) (11)
Enigmas in the pathogenesis of IgA nephropathy. (1995) (11)
1,25-dihydroxycholecalciferol enhances the expression of MHC class II antigens and intercellular adhesion molecule-1 by human renal tubular epithelial cells. (1996) (11)
Induction of C1q expression in glomerular endothelium in a rat model with arterial hypertension and albuminuria (2007) (11)
The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes. (1984) (11)
Renal graft dysfunction during infection with cytomegalovirus: association with IgM lymphocytotoxins and HLA-DR3 and DR7. (1983) (11)
Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration (2016) (11)
Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor. (1985) (11)
Tissue antigens in tubulointerstitial and vascular rejection. (1995) (11)
Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis (1988) (10)
Decreased expression of decay-accelerating factor on endothelial cells of immune complex-mediated vasculitic skin lesions. (1991) (10)
Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugates. (1997) (10)
Glomerular capillary wall charge and antibody binding in passive Heymann nephritis. (1988) (10)
Effects of C-1 on the size of soluble immune aggregates and on their processing by macrophages. (1979) (10)
Deficiency of complement component C3 is associated with accelerated removal of soluble 123I‐labelled aggregates of IgG from the circulation (1992) (10)
Activation of complement pathways in xenotransplantation: an in vitro study. (2002) (10)
Search for the antigen-specificity of homogeneous IgG components (H-IgG) after allogeneic bone marrow transplantation. (1996) (10)
Degradation of Soluble Immunoglobulin Aggregates in Vitro by Monocytes from Normal Subjects and from Patients with Systemic Lupus Erythematosus (1982) (10)
Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase. (1979) (10)
Anti-vitronectin antibodies enhance anti-Thy-1-induced proteinuria in PVG/c, but not in Wistar rats. (1998) (10)
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases? (2021) (9)
On the origin of the FcRIII (CD16)-containing vesicle population in human neutrophil granulocytes. (1991) (9)
Lymphokine-activated killer cells lyse human renal cancer cell lines and cultured normal kidney cells. (1988) (9)
Pegvaliase: Immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapy. (2019) (9)
Into the third century of complement research. (2000) (9)
Isolation of the fourth component (C4) of rat complement. (1979) (9)
IgA class anti-neutrophil cytoplasmic antibodies (IgA-ANCA) in primary IgA nephropathy. (1989) (9)
A cyclic GMP- and G-kinase-dependent effect of azathioprine on migration by human neutrophils (1997) (9)
Binding, internalization and degradation of soluble aggregates of human secretory IgA by resident rat peritoneal macrophages. (1988) (9)
Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option? (2019) (9)
Elimination of soluble 123I-labelled aggregates of human immunoglobulin G in humans; the effect of splenectomy. (1989) (9)
The bittersweet taste of tubulo-interstitial glycans. (2016) (9)
C5 deficiency in a white family. (1985) (9)
Isolation from purulent sputum of an antigen reactive with antibodies in serum of patients with Wegener's granulomatosis. (1990) (8)
Factors influencing the endocytosis of immune complexes. (1984) (8)
Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy. (1998) (8)
Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus. (1983) (8)
Respiratory Pathways of Macrophages — Cellular Localization and Relation to Cidal Activity (1980) (8)
EXCRETION OF UROKALLIKREIN IN RENAL TRANSPLANT PATIENTS: Relation to Graft Rejection, Renal Function, and Blood Pressure (1984) (8)
Complement, Coagulation and Mononuclear Phagocytes (1980) (8)
Experimental Streptococcus sanguis endocarditis: immune complexes and renal involvement. (1980) (8)
Complement-mediated enhancement of IgA-induced H2O2 release by human polymorphonuclear leucocytes. (1989) (8)
Interaction of immunoglobulin A with complement and phagocytic cells. (1989) (7)
Destructive and protective effects of antibody on transplants in humans: practical and theoretical considerations. (1986) (7)
Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo (2019) (7)
Pitfalls in urinary complement measurements. (2012) (7)
Participation ofImmunoglobulins andComplement Components intheIntracellular Killing ofStaphylococcus aureus andEscherichia coli byHumanGranulocytes (1981) (7)
In vivo modulation of rat complement activities by infusion of anti-H antibodies. (1985) (7)
Does haemodialysis impair macrophage Fc receptor function? (1992) (7)
Immuno-histological analysis of dendritic cells in nasal biopsies of IgA nephropathy patients. (2007) (7)
Hyperacute rejection in the guinea pig-to-rat model without formation of the membrane attack complex. (1999) (7)
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (7)
Epidemiology, baseline characteristics and risk of progression in the first South-Asian prospective longitudinal observational IgA nephropathy cohort (2020) (7)
Combined administration of IgA and IgG anti-Thy-1 antibodies enhances renal inflammation in rats. (1999) (7)
C3 Nephritic Factor (C3NeF): Heterogeneity, Polypeptide Chain Structure and Antigenic Reactivity (1978) (7)
Complement enhances the elimination of soluble aggregates of IgG by rat liver endothelial cells in vivo (1993) (7)
Pancreas and kidney allograft-infiltrating cells in simultaneous pancreas-kidney transplantation. (1997) (7)
Isolation and function of a human endothelial cell C1q receptor (1993) (7)
Blocking Complement Factor B Activation Reduces Renal Injury and Inflammation in a Rat Brain Death Model (2019) (6)
Immune complexes in leprosy patients from an endemic and a nonendemic area and a longitudinal study of the relationship between complement breakdown products and the clinical activity of erythema nodosum leprosum. (1982) (6)
Subacute cutaneous lupus erythematosus in a patient with inherited deficiency of the third component of complement. (1992) (6)
Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus. (1983) (6)
CsA, FK506, corticosteroids and rapamycin inhibit TNF alpha production by cultured PTEC. (1993) (6)
Role of proteinase 3 in activation of endothelium (2009) (6)
Studies on the haemolytic activity of circulating C1q-C3/C4 complexes. (2008) (6)
A novel rat mesangial matrix protein, MMP-50/100, involved in mesangial glomerulopathies. (1995) (6)
Complement C6 and C2 Biosynthesis in Syngeneic PVG/c− and PVG/c+ Rat Strains (1997) (6)
Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapies. (2021) (6)
Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3. (1980) (6)
Presentation of solid phase assays from several laboratories. (1990) (6)
Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages. (1983) (5)
Binding and degradation of soluble immunoglobulin aggregates by mouse mononuclear phagocytes--stimulation by colony-stimulating factor. (1982) (5)
Glomerulopathy induced by a single monoclonal autoantibody against GP330. (1995) (5)
Acute cellular rejection during effective early prophylactic OKT3 monoclonal antibody treatment after renal transplantation. (1989) (5)
Autoradiographical demonstration of C3b receptor activity on resident peritoneal macrophages (2004) (5)
Correlates of plasma atrial natriuretic peptide levels in renal transplant recipients. (1989) (5)
Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort (2018) (5)
Antigen size influences the type of glomerular pathology in chronic serum sickness. (1993) (5)
Risk alleles in complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) are independently associated with systemic complement activation in age-related macular degeneration (AMD) (2011) (5)
Glomerular mesangial uptake of intravenously injected colloidal carbon in the rat determined by an image analysing method: Lack of influence of platelet aggregation or complement activation (1980) (5)
Effects of soluble aggregates of IgG on the binding, uptake and degradation of the C1q subcomponent of complement by adherent guinea pig peritoneal macrophages. (1985) (5)
Human Umbilical Vein Endothelial Cells and Monocyte Chemoattractant Peptide-1 by C 1 q , Triggers the Production of IL-8 , IL-6 , The First Subcomponent of Complement (1998) (5)
T‐cell receptors and IC AM‐1 expression in renal allografts during rejection (1991) (5)
Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20 (2020) (5)
Diminished uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis and vasculitis. (1987) (5)
Role of liver endothelial and Kupffer cells in clearance of human Clq in rats (1993) (5)
Activation of the alternative pathway of complement by immune complexes and degradation of these complexes by macrophages. (1982) (4)
Studies on vitamin D and related compounds. Part 21. Photosensitized reactions (2010) (4)
Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy (2021) (4)
IL-17 and CD40-L act synergistically in the activation of human renal epithelial cells and can both be detected during renal allograft rejection (1997) (4)
Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells. (1988) (4)
In vivo evaluation of four hemodialysis membranes : biocompatibility and clearances (1995) (4)
Cytolysis of Free-Living Algae by Complement (1986) (4)
Pattern recognition and renal defence in crescentic glomerulonephritis. (2010) (4)
The bone marrow as a possible origin of the IgA1 deposited in the mesangium in IgA nephropathy. (1987) (4)
Erratum: Crosstalk between complement and toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury (American Journal of Transplantation (2011) 11 (660-669) DOI: 10.1111/j.1600-6143.2011. 03475.x) (2011) (4)
Macrophage activation by IgE. (1980) (4)
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury (2021) (4)
Stimulation of human polymorphonuclear leukocytes by serum IgA or secretory IgA. (1987) (4)
Complement System and Fc Receptors: Genetics (2006) (4)
MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides (2020) (4)
Is the renal kallikrein system relevant to sodium sensitivity in patients with essential hypertension (1985) (4)
C1q as Antigen in Humoral Autoimmune Responses (1999) (4)
The pathogenetic significance of circulating immune complexes. (1984) (4)
Antibodies directed against the cytoplasm of neutrophils and monocytes. (1990) (4)
Possible mechanisms of degradation of C1q in vivo and in vitro: role of macrophages. (1989) (4)
CD32 expression and signaling is down‐regulated by transforming growth factor‐β1 on human monocytes (1996) (4)
A rapid ELISA for measurement of anti-glomerular basement membrane antibodies using microwaves. (1993) (4)
The detection of circulating immune complexes containing immunoglobulin G. (1984) (3)
Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus. (1982) (3)
Effect of indomethacin on the synthesis of glomerular basement membrane and on proteinuria in rats with nephrotoxic nephritis. (1977) (3)
Biocompatibility of hemodialysis using cuprophane membranes. (1987) (3)
The Effect of Complement on the Degradation of Soluble Immune Aggregates by Kupffer Cells and Peritoneal Macrophages in Vitro (1980) (3)
Extracellular Stimulation of Intracellular Killing (1980) (3)
Renal Graft Dysfunction During Infection With Cytomegalovirus: Association With IgM Lymphocytotoxins and HLA-DR3 and DR7 (1984) (3)
Preface to the special issue. (2017) (3)
The involvement of Kupffer cells and liver endothelial cells in the clearance of large sized soluble IgA aggregates in rats. (1995) (3)
Deposition of IgA is Associated with Macrophage Influx in the Kidney of Rats (1991) (3)
PERIVASCULAR DEPOSITS OF IgM IN THE SKIN OF TRANSPLANT RECIPIENTS DURING ACTIVE CYTOMEGALOVIRUS INFECTIONS CORRELATION WITH IGM RHEUMATOID FACTORS AND IGM IMMUNE COMPLEXES (1987) (3)
The influence of haemoperfusion on white cells, immunoglobulin concentrations and the complementsystem in the treatment of intoxications (1983) (3)
IgM immune complexes, lymphocytotoxins, and rheumatoid factors in renal transplant recipients with CMV disease. (1985) (3)
Blocking complement activation in general, and complement factor 5a in particular, inhibits intimal hyperplasia and accelerated atherosclerosis in murine vein grafts (2006) (3)
Effects of posture and saline infusion on atrial natriuretic peptide and haemodynamics in patients with Bartter's syndrome and healthy controls (1988) (3)
Crosslinking of the Human Fc Receptor for IgA (FcαRI/CD89) Triggers FcR γ-Chain-Dependent Shedding of Soluble CD89 (1999) (3)
The mucosal immune system in IgA nephropathy (1997) (3)
Influence of Complement Components on the Size and the Opsonization of DNA‐Anti‐DNA Complexes (1982) (3)
Enhanced Binding and Degradation of the C1q Subcomponent of Complement by Thioglycollate‐Stimulated Guinea Pig Peritoneal Macrophages (1986) (3)
Synthesis and degradation of glomerular basement membrane in rats with nephrotoxic nephritis. (1978) (3)
Human Complement Component C3b (2005) (3)
Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells. (1988) (3)
A C1q domain containing factor evidenced in the leech nerve cord expressed a chemotactic activity on microglial cells (2008) (2)
Regulatory role of C1q in the inflammatory status of macrophages (2007) (2)
Modulation of the expression of membrane-bound complement regulators on human renal tumor cell lines by cytokines affects C3 deposition and tumor cell lysis (1998) (2)
Purification and functional analysis of human properdin. (2014) (2)
Activation of the alternative pathway of complement by human serum IgA. (1987) (2)
Ig-class specificity of ANCA. (1990) (2)
Tumor Cell Lysis by Complement Antigen G250 Enhances C3 Deposition and Regulator CD55 and the Renal Tumor-Associated Against Both the Membrane-Bound Complement A Bispecific Monoclonal Antibody Directed (1998) (2)
A newly discovered function of the erythrocyte: transport of immune complexes to the liver. (1992) (2)
Presence of ANCA in sera of uveitis patients (1990) (2)
Effect of monomeric immunoglobulin G (IgG) on the clearance of soluble aggregates of IgG in man. (1991) (2)
Evaluation of the efficiency of two IgA immune complex assays. (1990) (2)
Memories of Bob Sim—Genius Complementologist and Cheerful Travel Companion (2021) (2)
Three-Year Clinical Outcomes of the First South Asian Prospective Longitudinal Observational IgA Nephropathy Cohort (2021) (2)
Isolation of the fourth component (C4) of the rat complement system. (1980) (2)
Characteristics of anti-Legionella antibodies in patients infected with Legionella pneumophila serogroups 1, 6, and 10 (1988) (2)
Pre-transplantation MBL levels predict patient and graft survival after simultaneous pancreas–kidney transplantation (2007) (2)
Machine perfused donor kidneys as a source of human renal endothelial cells. (2021) (2)
Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis. (1990) (2)
Binding and degradation of soluble aggregates of IgA by rat peritoneal macrophages. (1987) (2)
Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney (2022) (2)
Concluding remarks on solid phase assays. (1990) (2)
Different functional activities of T cell lines isolated from a rejected renal allograft and peripheral blood lymphocytes of renal transplant recipients. (1988) (1)
Inhibition of classical pathway activation by human neutrophil defensions (1998) (1)
Inactivation of kallikrein during sepsis and bacterial shock (2005) (1)
Expression and Function of CD40 on Various Cell Types (2001) (1)
Therapeutic targeting of classical and lectin pathways of Complement protects from ischemia-reperfusion induced renal damage inhibiting the activation of dendritic cells (2009) (1)
Induction of apoptosis by the terminal sequence of complement (2000) (1)
Lymphocytes T + Captured in Immune Complexes to CD 8 Augmenting the Presentation of Antigen A Novel Role of Complement Factor C 1 q in (2007) (1)
Soluble CD59 in peritoneal dialysis: a potential biomarker for peritoneal membrane function (2020) (1)
Diagnostic value of immunological investigations on sera of patients with glomerulonephritis. (1989) (1)
Brain death‐induced lung injury is complement dependent, with a primary role for the classical/lectin pathway (2020) (1)
Interaction of mannan-binding lectin with IgA (2000) (1)
PRIMARY AND SECONDARY GLOMERULONEPHRITIDES 1 (2014) (1)
[The complement system and clinical effects of its disorders]. (1996) (1)
Methods for the Detection of Circulating Immune Complexes (1981) (1)
Anti-myeloperoxidase antibodies and clinical associations. (1990) (1)
ERA-EDTA Immunonephrology working group. (2010) (1)
Comparison of IgG, IgA, and IgM preparations for their capacity to scavenge the activated complement components C4b and C3b: 634 (1997) (1)
Expression of the interleukin-2 receptor on human renal proximal tubular epithelial cells (1997) (1)
The development of an ex vivo model for hemodialysis to mimic membrane induced complement activation (2018) (1)
Complement receptor 1 (CR1, CD35) binds CpG-DNA (2011) (1)
A further case of hereditary C1q-deficiency in a Turkish family from the Netherlands: Analysis of the defected gene and mRNA☆ (1998) (1)
Cyclosporine and other therapy-resistant nephrotic syndrome. (1988) (1)
Low mannose-binding lectin levels predict cardiovascular disease in hemodialysis patients (2016) (1)
Author and Subject Index (1999) (1)
Modulation of toll-like receptor mediated maturation of professional human antigen-presenting cells by the complement inhibitor low molecular weight dextran sulfate (2007) (1)
Mitogenic stimulation of malignant B cells CLL: diminished in-vitro stimulation with anti-CR1 antibodies. (1988) (1)
The possible role of membrane complement regulators in vasculitis. (1993) (1)
The role of complement in macrophage functions (1985) (1)
Contents Vol. 60, 1999 (1999) (1)
The role of cellular Fc- and C3-receptors (C3R) in the complement (C) — dependent degradation of soluble immunoglobulin aggregates (AlgG) by normal peritoneal macrophages (MØ). (1982) (1)
Properdin binding independent of complement activation in an in vivo model of anti-GBM disease (2018) (1)
A five day course of high dose corticosteroids has no effect on the clearance of soluble aggregates of human immunoglobulin G in healthy volunteers. (1992) (1)
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (1)
C1q and the glomerulonephritides: therapeutic approaches for the treatment of complement-mediated kidney diseases (2006) (1)
Enhanced oxidative stress in the initiation and progression of Thy‐1 nephritis (2007) (1)
Early steps of allergen induced activation of the classical pathway of complement (1998) (1)
Novel Approaches to Control of the Alternative Complement Pathway for the Treatment of C3 Glomerulopathies. (2018) (1)
Dendritic cells express alternative pathway components properdin and factor H : Differential regulation by Interferons and IL-27 (2013) (1)
Incidence and clinical significance of circulating immune complexes in glomerulonephritis. (1984) (0)
Low mannose-binding lectinlevels predict cardiovascular disease in hemodialysis patients (2016) (0)
Isolation of Alternative Pathway C3 Convertases Formed in the Presence of C3 Nephritic Factor (C3NeF) (1976) (0)
RANTES production by human proximal tubular epithelial cells (PTEC) in vitro (1997) (0)
Collectins C 1 qProteoglycans Decorin and Biglycan with Interactions of the Extracellular Matrix (2005) (0)
Chapter The role of SIgA and complement in IgA-nephropathy (2008) (0)
Activation of rat complement by soluble and insoluble immune complexes of rat IgA. (1988) (0)
Hypoxia induces complement activation on kidney proximal tubular epithelial cells (2008) (0)
Modulation of disease in an experimental complement-dependent murine model of renal inflammation (2008) (0)
Contents Vol. 134, 2004 (2004) (0)
CellsTargets Apoptotic Cells to Dendritic Opsonization with C1q and Mannose-Binding (2017) (0)
Low pre-transplantation Mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation (2009) (0)
Urinary C5b-9 is an Independent Predictor of Graft Failure in Renal Transplant Recipients. (2018) (0)
Endothelial Cell Damage in Immune Comrlex Vasculitis of the Skin: Ultrastructura Localization of the Membrane Attack Complex (1989) (0)
NOVEL ENDOTHELIAL CELL BASED ASSAY TO STUDY COMPLEMENT DEPENDENT CYTOTOXICITY (2017) (0)
Mechanisms of properdin induced renal injury (2009) (0)
Biological properties of immune complexes. (1984) (0)
Serogroup B meningitidis Neisseria Immune Defense Against Activity of Human IgG and IgA Subclasses in and (2001) (0)
An Enzyme-Linked Immunosorbent Assay-Based Method for Functional Analysis of the Three Pathways of the Complement System (2006) (0)
Lectin Targets Apoptotic Cells to Dendritic Opsonization with C 1 q and Mannose-Binding Kooten (2004) (0)
Both nucleosomes and C1q bind to glomerular endothelial cells in vitro, serve as targets for autoantibodies and determine complement activation (2011) (0)
54 RECURRENT INFECTIONS OF RESPIRATORY TRACT WITH GRAMBACTERIA DUE TO OPSONIC DEFECT IN FACTOR D‐DEFICIENCY (1986) (0)
comment ‘ Stealth ’ corporate innovation : an emerging threat for therapeutic drug development Therapeutic innovations of potentially great clinical impact should embrace the overarching values of research accountability , data transparency and validation through the scientific peer-review process (2019) (0)
Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity (2000) (0)
Chapter De(cid:2) cient IgAl immune response to nasal cholera toxin subunit B in primary IgA nephropathy (2008) (0)
496 LECTIN COMPLEMENT PATHWAY GENES OF DONOR AND RECIPIENT DETERMINE THE RISK OF CLINICALLY SIGNIFICANT INFECTIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION (2010) (0)
Immunobiology of the Complement System. Gordon D. Ross, editor. Orlando, Academic Press, 1986. 273 pages. Illustrated. Indexed. $45.50 (1987) (0)
C A L M E C H A N I S M S A N D I N T R E A T M E NT APPROACH E S (2010) (0)
serogroups 1, 6, and 10. patients infected with Legionella pneumophila Characteristics of anti-Legionella antibodies in (2013) (0)
The expression of membrane-bound regulators of complement activation on human renal tumor cell lines can be modulated by cytokines (1997) (0)
337 Donor and Recipient Lectin Complement Pathway Genes Determine the Risk of Clinically Significant Infections After Orthotopic Liver Transplantation (2010) (0)
Isolation andcharacterization ofratcomplement factor B andits interaction withcell-bound humanC3 (1980) (0)
Antibody and complement dependent regulation of apoptosis in anti-Thy.1 nephritis in rats (1998) (0)
The Specificity of the Autoimmune Response in Vasculitis (1991) (0)
Complement component C2a (2006) (0)
University of Groningen Complement Activation During lschemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling (2018) (0)
Neutrophil components as regulators of the complement system (2013) (0)
Localization of Fcγ receptors in human neutrophils by immunoelectromicroscopy (1987) (0)
Increased urinary excretion of monocyte ehemoattractant protein-1 during acute renal allograft rejection (2005) (0)
Deficiency of C4 from brain death mice protects against renal injury (2017) (0)
Activation of complement by soluble IgG aggregates and their subsequent interaction with macrophages. (1987) (0)
Interaction of IgA with Complement and Phagocytes (1989) (0)
Complement activation and vascular complications in type 2 diabetic South Asians (2011) (0)
of Angiotensin I I a nd T ransforming G rowth F actor /3 on the Production of Heparan Sulfate Proteoglycan by Mesangial Cells In Vitro1 (1996) (0)
The classical pathway of complement (2017) (0)
Clinical Significance of Laboratory Investigations for Immune Complexes (1985) (0)
Experimental pathology - 1 (2009) (0)
Modulation of T cell effector function by concanavalin A. (1988) (0)
New insights into the pathogenesis of IgA nephropathy (2014) (0)
Faculty Opinions recommendation of The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait. (2005) (0)
Involvement of Minor Histocompatability Antigens in the Rejection of an HLA Identical Renal Transplant from a Living Related Donor (1995) (0)
Human anti-citrullinated protein antibodies (ACPA) not only activate the classical- but also the alternative complement pathway (2009) (0)
Hemodialysis patients with cardiovascular event have unfavorable complement profile (2017) (0)
abnormalities inthenormal skin ofpatients withrheumatoid arthritis inrelation to clinical andserological findings: aone yearfollow up study (2011) (0)
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (0)
Role of native properdin in the control leptospirosis infection (2011) (0)
Subject Index Vol. 7, 1999 (1999) (0)
Evaluation of Serum Complement Levels in Age-Related Macular Degeneration (amd) (2010) (0)
IgM-enriched IVIG preparations are efficient ‘scavengers’ of C4 as well as C3 and prevent complement-dependent cytotoxicity of human serum against pig cells (1997) (0)
Administration of intravenous iron preparations induces complement activation in anemic patients (2017) (0)
Induction of apoptosis of endothelial cells by proteinase 3 (PR3): a possible mechanism of vascular injury in Wegener's granulomatosis (1997) (0)
Therapeutic Targeting of Classical and Lectin Pathways of Complement (C) Protects the Kidney from Ischemia-Reperfusion (I/R) Injury Inhibiting the Activation of Dendritic Cells. (2009) (0)
The influence of a new complement gene polymorphism on kidney transplant outcome (2018) (0)
Structural insights into the central complement component C3 (2005) (0)
Immune complex bound C1q enhances complement activation on glomerular endothelial cells (2009) (0)
Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients (2016) (0)
Mannan binding lectin (MBL) is present in human lung tissue and is expressed by human lung mast cells (2003) (0)
The uptake of αFcR-gold by human neutrophil granulocytes (1988) (0)
Poster Presentations (2013) (0)
Analysis of pancreas and kidney graft infiltrating T cells (1997) (0)
Contents, Vol. 22, 1978 (1973) (0)
Subject Index, Vol. 60, 1992 (1992) (0)
Improvement of heparan sulfate expression in the skin basement membrane after kidney and pancreas-kidney transplantation* (1999) (0)
Rapamycin speciﬁcally interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27 KIP1 expression (2003) (0)
Comparable binding of monomeric and polymeric IgA to the novel IgA Fc receptor, Fc (cid:2) /µR. (2007) (0)
Analysis of systemic complement in experimental renal injury and disease (2017) (0)
Maturation of Human Dendritic Cells TLR4-Induced Phenotypic and Functional Weight Dextran Sulfate Prevents The Complement Inhibitor Low Molecular (2008) (0)
StateCovalently Linked to IgA in a Polymeric RI / CD 89 Circulates in Human Serum α (2002) (0)
Zinc supplementation lowers complement overactivation in patients with age-related macular degeneration (2013) (0)
SaO005ADMINISTRATION OF INTRAVENOUS IRON PREPARATIONS INDUCES COMPLEMENT ACTIVATION IN PATIENTS (2018) (0)
Mannose-binding lectin induces tubular epithelial cell death following renal ischemia reperfusion injury independent of complement activation (2011) (0)
Inhibition of Complement Component C3 Reduces Vein Graft Atherosclerosis in ApoE3Leiden Transgenic Mice. (2008) (0)
Increased renal C5a receptor expression and systemic complement activation in brain dead donors (2011) (0)
Faculty Opinions recommendation of The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. (2007) (0)
Complement C1Q induced production of IL-6, IL-8 and MCP-1 by human umbilical vein endothelial cells (HUVEC) (1997) (0)
Hypoxia induces complement activation on HUMAN kidney proximal tubular epithelial cells via the classical pathway (2009) (0)
Resistance to proteinuria development in anti-Thy-1 glomerulonephritis is governed by both renal and bone marrow-derived factors (2009) (0)
Using extremes to identify rare pathogenic variants in age-related-macular degeneration (2013) (0)
Crosslinking of the human Fc receptor for IgA (CD89) triggers FcR gamma-chain dependent shedding of soluble CD89 (2000) (0)
HumoralImmuneResponsetoInfluenza Vaccination inPatients withPrimary Immunoglobulin A Nephropathy AnAnalysis ofIsotype Distribution andSizeoftheInfluenza-specific Antibodies (1989) (0)
Binding characteristics of human serum IgA to CD89 (1997) (0)
Measurement of soluble C5b-9 and pathway specific complement activation in a rat model of renal ischemia/reperfusion injury (2013) (0)
in primary IgA nephropathy (1996) (0)
A method for functional detection of MASPs and its complex (2005) (0)
Abstracts of papers clinical pharmacological meeting (2005) (0)
Expression and Function of CD40 on Hematopoietic and Non-Hematopoietic Cells (2001) (0)
Study of complement activation in a life supporting pig to primate xenotransplantation model using GAL KO pigs (2011) (0)
Nephritis in Mice Antiglomerular Basement Membrane Required for Development of Attenuated Both Complement and IgG Fc Receptors Are (2009) (0)
Recombinant human C1-inhibitor reduces early tissue damage in a swine model of ischaemia/reperfusion injury (2008) (0)
T-Cell Receptor V-Gene Usage in T-Cell Lines Propogated from Graft-Infiltrating T Lymphocytes in Needle Biopsies of Rejecting Renal Allografts (1995) (0)
Thebonemarrow asproduction site oftheIgAdeposited in thekidneys ofpatients withIgAnephropathy (1988) (0)
Serumlevels andinvitro production ofIgAsubclasses in patients withprimary IgAnephropathy (1988) (0)
Globular Head Region Interacts with C-Reactive Protein through Its Evidence That Complement Protein C1q (2006) (0)
The Effect of Sodium Aurothiomalate on Stimulated and Non-Stimulated Migration by Human Neutrophils: The Role of Cyclic GMP (1997) (0)
[The pathogenesis of primary IgA-nephropathy]. (1990) (0)
Fluorescence in situ hybridisation to analyse DAF transgenic jigsaw pigs. (1996) (0)
Pathogenic significance of autoantibodies against C1q in the development of renal disease (1999) (0)
RENAL TUBULAR EPITHELIAL CELLS ARE ACTIVE PARTICIPANTS IN THE REGULATION OF INTERSTITIAL INFILTRATION IN THE KIDNEY.: Abstract# 1020 (2000) (0)
Bi-specific monoclonal antibodies directed against CD55 and a cell-surface antigen and their effect on human renal tumor cells (1997) (0)
Complement-mediated injury of human glomerular endothelial cells by anti-C1q antibodies (2008) (0)
A functional role for complement receptor C5L2 in the pathogenesis of renal ischemia-reperfusion injury (2016) (0)
Properdin binding to the surface of leptospira promotes complement activation and controls proliferation of non-pathogenic bacteria in vitro (2012) (0)
[Immunology in medical practice. IV. Mechanisms in the development of primary nephropathies]. (1998) (0)
Robust measurement of rat complement system activation with novel ELISA-based assays (2012) (0)
Dendritic Cells Phenotypic and Functional Maturation of Human Weight Dextran Sulfate Prevents TLR4-Induced The Complement Inhibitor Low Molecular (2011) (0)
A novel ELISA-based assay for the measurement of the three activation pathways of the complement system (2005) (0)
EXPRESSION OF HUMAN PROTEINASE 3 IN CHINESE HAMSTER OVARY CELLS (CHO-CELLS) (2000) (0)
In memoriam—Leendert C. Paul, MD, 1946–2004 (2004) (0)
Retina Allergy Is a Protective Factor Against Age-Related Macular Degeneration (2014) (0)
Peptides Complement Pathway by C 1 q-Binding Specific Inhibition of the Classical (2001) (0)
The value of the indirect immune fluorescence test and solid phase assays for anca detection (1991) (0)
Characterization of the glomerular endothelial binding sites for full-length complement factor H (FH) and for FH19–20 and FH5–7 domains (2011) (0)
Deficiency of early complement components protects against renal injury in a mouse model of brain death (2018) (0)
Complement and the kidney (2009) (0)
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (0)
Complement, its role in innate immunity and autoimmunity (2003) (0)
Fourth European meeting on complement in human disease. (1992) (0)
University of Groningen Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus Bultink, (2015) (0)
Fourth European Workshop on Inflammation Wilrijk March 1982 (1982) (0)
Towards precision medicine in AMD : Genome-wide association study reveals genetic variants in CFH and CFHR4 that are strongly associated with complement activation levels (2017) (0)
Protective role of complement C3 gene variants on renal transplant outcome of deceased cardiac death donor kidneys (2011) (0)
Blocking of the Chemotactic Complement Endproduct C5a Inhibits Accelerated Atherosclerosis in Vein Grafts (2008) (0)
Functionalassessmentofmouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury☆ (2015) (0)
Intracellular localization and de novo synthesis of FcRIII in neotrophil granulocytes (1989) (0)
Characteristics ofAnti-Legionella Antibodies inPatients Infected withLegionella pneumophila Serogroups 1,6,and10 (1988) (0)
Regulation ofC3andfactor H synthesis ofhumanglomerular mesangial cells byIL-1andinterferon-gamma (1994) (0)
Control of the amplification convertase of complement by the plasma protein j 1 lH ( amplification convertase inhibitor / C 3 b inactivator / properdin / C 3 nephritic factor / alternative complement pathway ) (2003) (0)
Editorial Acknowledgment (2004) (0)
IgG antibody aggrevates the renal inflammation in an experimental model of IgA nephropathy in rats (1997) (0)
Anti-C1q autoantibodies modulate proteinuria in lupus-prone MRL/lpr mice (2007) (0)
Pulmonary Hypertension in Lung Disease : a Key Role for Gremlin (2008) (0)
CHAPTER 3 M BL and type I diabetes Elevated Levels of M annose Binding Lectin at Clinical M anifestation of Type 1 Diabetes in Juveniles (2006) (0)
Inhibition of toll-like receptor induced phenotypic and functional maturation of human dendritic cells by the complement inhibitor low molecular weight dextran sulfate (2007) (0)
Subject Index Vol. 134, 2004 (2004) (0)
10 Inhibition of complement component C3 reduces vein graft atherosclerosis in ApoE3*Leiden transgenic mice (2008) (0)
Pathogenesis, pathophysiology and treatment of glomerulonephritis and vasculitis (2002) (0)
CellsLectin Targets Apoptotic Cells to Dendritic Opsonization with C1q and Mannose-Binding (2004) (0)
Functional assessment of the three complement pathways of mouse complement system and quantification of mouse C3b/C3c/iC3b complex in circulation (2013) (0)
Inhibition of mannose-binding lectin preserves renal function in a rat model of renal ischemia reperfusion injury (2010) (0)
P05 IDENTIFICATION OF GLYCOSAMINOGLYCANS THAT SPECIFICALLY INHIBIT THE LECTIN PATHWAY OF COMPLEMENT (2016) (0)
Faculty Opinions recommendation of Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q. (2006) (0)
List of reviewers for 2007 (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mohamed r. Daha?

Mohamed r. Daha is affiliated with the following schools:

Mohamed r. Daha's Academic­Influence.com Rankings

Why Is Mohamed r. Daha Influential?

Mohamed r. Daha's Published Works

Published Works

What Schools Are Affiliated With Mohamed r. Daha?

Mohamed r. Daha's AcademicInfluence.com Rankings